We also examined T2D association summary statistics at lead SNPs for 37 established T1D susceptibility loci. For each of these SNPs, we reported the allelic OR (aligned to the T2D risk-allele) and P-values in: (i) our Stage 1 T2D meta-analysis; and (ii) a GWAS meta-analysis of 7,514 T1D cases and 9,045 population controls from European descent populations from the Type 1 Diabetes Genetics Consortium35 (link).
Insulin
It facilitates the uptake of glucose by cells, promoting its storage as glycogen and fat.
Insulin also plays a role in protein and lipid metabolism.
Disruptions in insulin production or signaling can lead to conditions like diabetes mellitus.
Researchers use a variety of insulin-related products and procedures to investigate the underlying mechanisms and potential therapies for insulin-related disorders.
PubCompare.ai can help optimize your insulin research by locating the best protocols from literature, pre-prints, and patents, enhancing reproducibility and accuracy to ensure you find the most effective insulin-related products and procedures.
Explore PubComapre.ai today and take your insulin research to the next level.
Most cited protocols related to «Insulin»
We also examined T2D association summary statistics at lead SNPs for 37 established T1D susceptibility loci. For each of these SNPs, we reported the allelic OR (aligned to the T2D risk-allele) and P-values in: (i) our Stage 1 T2D meta-analysis; and (ii) a GWAS meta-analysis of 7,514 T1D cases and 9,045 population controls from European descent populations from the Type 1 Diabetes Genetics Consortium35 (link).
Candidate predictors identified at bootstrap analysis were evaluated using three stepwise logistic models before obtaining a final prediction model (probability to enter = 0.01 and probability to remove = 0.02; these more stringent levels were used to protect against type I errors). The goodness of fit of the models was evaluated using the Hosmer-Lemeshow statistic and their accuracy was assessed by calculating the non-parametric area (AUC) under the receiver-operating curve (ROC) with 95% confidence intervals (95%CI) [23 ,24 ]. The standard errors of the regression coefficients of the final model were calculated using 1000 bootstrap samples of 496 subjects. The probabilities obtained from the final model were multiplied by 100 to obtain the fatty liver index (FLI). The sensitivity (SN), specificity (SP), positive likelihood ratio (LR+) and negative likelihood ratio (LR-) of 10-value intervals of FLI were calculated [23 ]. Statistical analysis was performed using STATA 9.2 (StataCorp, College Station, Texas, USA).
We included three design classes of SNPs on the Metabochip (
In total, 217,695 SNPs were chosen for the array (
We also searched the National Human Genome Research Institute (NHGRI) GWAS Catalog for previous SNP-trait associations near our lead SNPs73 (link). We supplemented the catalog with additional genome-wide significant SNP-trait associations from the literature13 (link),70 (link),74 (link)-80 (link). We used PLINK to identify SNPs within 500 kb of lead SNPs using 1000 Genomes Project Pilot I genotype data and LD (r2) values from CEU81 (link),82 (link); for rs7759742, HapMap release 22 CEU data81 (link),83 (link) were used. All SNPs within the specified regions were compared with the NHGRI GWAS Catalog16 .
Most recents protocols related to «Insulin»
Example 3
Human primary sebocytes (Zenbio, RTP, NC) were plated at confluence on 96 well Scintiplates and allowed to adhere overnight. Cells were treated with the SCD1 inhibitor Compound A prepared in media containing the LXR agonist and insulin and cultured overnight. The DGAT inhibitor A922500 (2 μM) was included as a positive control. The following day 14C-acetate was added to each well and the plate was gently mixed. Cells were placed in the incubator at 37° C. for 4 hours total. After 2 hours of incubation the Cell Titer Blue (CTB) assay was started, 10 μl of CTB reagent was added to each well and incubated for the remaining 2 hours at 37° C. Following the 4 hour incubation, the RFU was determined using the SpectraMax Gemini EM under the following parameters: 560ex/590em with a 570 cutoff, top read. The medium was removed and cells were washed 3× with PBS. All of the PBS was removed from the wells and the plates were allowed to air dry. The plate was read in the MicroBeta TriLux counter and data was analyzed as CPM and normalized to CTB readout. Data is shown in
Example 10
Spray-dried disodium FDKP/insulin powder as described in Examples 6 or 7 is packed into hard gelatin capsules. The capsules can contain approximately 50-100 mg of powder. The FDKP salt/insulin powders prepared in Examples 6 and 7 were 25% insulin by weight and insulin activity was about 26 units/mg. Thus, 50 mg would be on the order of 1300 units, significantly larger than a typical dose. About 2-30 mg of the FDKP salt/insulin powder is mixed with methyl cellulose (other bulking agents are well known in the art) to make up the balance of the desired mass.
Example 6
To investigate the effect of insulin on CNS signaling, LA1-55 neuroblastoma cells were treated for 1 hour with 200 nM of insulin. The results are shown in
Additionally, activation of CNS p-Ser-473-Akt, p-Thr-55/560-aPKC, BACE1, aPKC activity and Aβ1-40/42 levels, by insulin in various mouse models was evaluated. Results are shown in
Example 11
Capsules containing the FDKP salt and insulin are taken before a meal. The exact dosage is patient-specific, but generally on the order of approximately 10-150 units of insulin is administered per dose. The subsequent insulin absorption attenuates post-prandial blood glucose excursions. This oral insulin formulation is used to replace pre-meal insulin injections in patients with diabetes. Additionally, insulin absorbed through the gastrointestinal tract mimics endogenous insulin secretion. Endogenous insulin is secreted by the pancreas into the portal circulation. Insulin absorbed following oral administration also goes directly to the portal circulation. Thus, the oral route of insulin administration delivers insulin to its site of action in the liver, offering the potential to control glucose levels while limiting systemic exposure to insulin. Oral insulin delivery using a combination of insulin and the diacid form of FDKP is hindered by the poor solubility of the FDKP diacid in the low pH environment of the gastrointestinal tract. The FDKP salts, however, provide a local buffering effect that facilitates their dissolution in low pH.
Example 9
These include any type of insulin pumps, chemotherapy pumps, pain killers-administration pump, intrathecal pumps, diuretic pumps, and alike, which work via a closed-loop integrating into their operating systems methods or algorithms which incorporate personalized-variability pattern(s).
Managing patients with severe insulin resistance is challenging because it is difficult to achieve good glycemic control using conventional treatment approaches. The algorithm identifies patterns of variability in glucose levels in each subject and implement them into a treatment schedule of the basal-bolus insulin pump which alters the regularity of the dosages and intervals between dosages, as a method for alleviating resistance and reducing overall insulin requirement. For pain-killer pumps, the goal is reducing the amount of painkillers administered to the patient by implementing inherent variability patterns into the treatment algorithm.
Top products related to «Insulin»
More about "Insulin"
It facilitates the absorption of glucose by cells, promoting its storage as glycogen and fat.
Insulin also influences protein and lipid (fat) metabolism.
Disruptions in insulin production or signaling can lead to conditions like diabetes mellitus, a common metabolic disorder characterized by high blood sugar levels.
Researchers utilize a variety of insulin-related products and procedures, such as FBS (Fetal Bovine Serum), dexamethasone, hydrocortisone, and penicillin/streptomycin, to investigate the underlying mechanisms and potential therapies for insulin-related disorders.
The culture media DMEM and DMEM/F12 are often used in insulin-related research, while growth factors like EGF (Epidermal Growth Factor) and cholera toxin may be incorporated to support cell growth and differentiation.
PubCompare.ai can help optimize your insulin research by locating the best protocols from literature, pre-prints, and patents, enhancing reproducibility and accuracy to ensure you find the most effective insulin-related products and procedures.
Explore PubCompare.ai today and take your insulin research to the next level.